{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:41:39Z","timestamp":1791859299326,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,30]],"date-time":"2019-11-30T00:00:00Z","timestamp":1575072000000},"content-version":"vor","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jsbmb.2018.09.001","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:11:13Z","timestamp":1536106273000},"page":"189-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase"],"prefix":"10.1016","volume":"185","author":[{"given":"Vitor Won-Held","family":"Rabelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane de Jesus","family":"Viegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erline Machado Neves","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelilma Correia","family":"Romeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Alvarez","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2018.09.001_bib0005","unstructured":"GAFFI. Global Action Fund for Fungal Infections. Fungi and fungal infections. Retrieved from: https:\/\/www.gaffi.org\/why\/fungi-fungal-infections\/."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.09.001_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.fbr.2011.01.003","article-title":"Microbial pathogens in the fungal kingdom","volume":"25","author":"Heitman","year":"2011","journal-title":"Fungal Biol. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.09.001_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/MMBR.00045-10","article-title":"Regulatory circuitry governing fungal development, drug resistance, and disease","volume":"75","author":"Shapiro","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.09.001_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1130-1406(05)70048-6","article-title":"Genomics, molecular targets and the discovery of antifungal drugs","volume":"22","author":"Odds","year":"2005","journal-title":"Rev. Iberoam. Micol."},{"issue":"5","key":"10.1016\/j.jsbmb.2018.09.001_bib0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1360-1385(98)01233-3","article-title":"Plant sterols and the membrane environment","volume":"3","author":"Hartmann","year":"1998","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/642502","article-title":"Sterol biosynthesis pathway as target for anti-trypanosomatid drugs","volume":"2009","author":"De Souza","year":"2009","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"issue":"1-4","key":"10.1016\/j.jsbmb.2018.09.001_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12154-008-0010-6","article-title":"Sterols and membrane dynamics","volume":"1","author":"Dufourc","year":"2008","journal-title":"J. Chem. Biol."},{"issue":"19","key":"10.1016\/j.jsbmb.2018.09.001_bib0040","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","article-title":"The biology and chemistry of antifungal agents: a review","volume":"20","author":"Kathiravan","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"7013","key":"10.1016\/j.jsbmb.2018.09.001_bib0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature02993","article-title":"Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase","volume":"432","author":"Thoma","year":"2004","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jsbmb.2018.09.001_bib0050","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1128\/AAC.38.9.1904","article-title":"Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide","volume":"38","author":"Balliano","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"18","key":"10.1016\/j.jsbmb.2018.09.001_bib0055","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1016\/0040-4020(95)00213-R","article-title":"Synthesis of vinyl sulfide analogs of 2,3-oxidosqualene and their inhibition of 2,3-oxidosqualene lanosterol-cyclases","volume":"51","author":"Zheng","year":"1995","journal-title":"Tetrahedron"},{"issue":"2","key":"10.1016\/j.jsbmb.2018.09.001_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/jm960483a","article-title":"Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase","volume":"40","author":"Stach","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jsbmb.2017.05.002","article-title":"Design strategies of oxidosqualene cyclase inhibitors: targeting the sterol biosynthetic pathway","volume":"171","author":"Rabelo","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7607","key":"10.1016\/j.jsbmb.2018.09.001_bib0075","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0085","doi-asserted-by":"crossref","first-page":"W597","DOI":"10.1093\/nar\/gkt376","article-title":"Analysis tool web services from the EMBL-EBI","volume":"41","author":"Mcwilliam","year":"2013","journal-title":"Nucl. Acids Res"},{"issue":"W1","key":"10.1016\/j.jsbmb.2018.09.001_bib0090","doi-asserted-by":"crossref","first-page":"W580","DOI":"10.1093\/nar\/gkv279","article-title":"The EMBL-EBI bioinformatics web and programmatic tools framework","volume":"43","author":"Li","year":"2015","journal-title":"Nucl. Acids Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.09.001_bib0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling","volume":"22","author":"Arnold","year":"2006","journal-title":"Bioinformatics"},{"issue":"suppl. 1","key":"10.1016\/j.jsbmb.2018.09.001_bib0100","first-page":"S162","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"issue":"5","key":"10.1016\/j.jsbmb.2018.09.001_bib0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/tcr.20157","article-title":"Sacharomyces cerevisiae oxidosqualene-lanosterol cyclase: a chemistry-biology interdisciplinary study of the protein\u2019s structure-function-reaction mechanism relationships","volume":"8","author":"Wu","year":"2008","journal-title":"Chem. Rec."},{"issue":"13","key":"10.1016\/j.jsbmb.2018.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"15","key":"10.1016\/j.jsbmb.2018.09.001_bib0115","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Cryst."},{"issue":"5016","key":"10.1016\/j.jsbmb.2018.09.001_bib0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1126\/science.1853201","article-title":"A method to identify protein sequences that fold into a known three-dimensional structure","volume":"253","author":"Bowie","year":"1991","journal-title":"Science"},{"issue":"6364","key":"10.1016\/j.jsbmb.2018.09.001_bib0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/356083a0","article-title":"Assessment of protein models with three-dimensional profiles","volume":"356","author":"Luthy","year":"1992","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jsbmb.2018.09.001_bib0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/prot.340170404","article-title":"Recognition of errors in three-dimensional structures of proteins","volume":"17","author":"Sippl","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0145","doi-asserted-by":"crossref","first-page":"W116","DOI":"10.1093\/nar\/gkl282","article-title":"CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues","volume":"34","author":"Dundas","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.09.001_bib0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comp. Chem."},{"issue":"16","key":"10.1016\/j.jsbmb.2018.09.001_bib0155","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","article-title":"Molecular docking","volume":"443","author":"Morris","year":"2008","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.jsbmb.2018.09.001_bib0165","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/ci200097m","article-title":"Pharmer: efficient and exact pharmacophore search","volume":"51","author":"Koes","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0170","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gks378","article-title":"ZINCPharmer: pharmacophore search of the ZINC database","volume":"40","author":"Koes","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyah","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0180","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0185","series-title":"Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests","author":"The United States Pharmacopeia","year":"2009"},{"issue":"15","key":"10.1016\/j.jsbmb.2018.09.001_bib0190","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1073\/pnas.91.15.7370","article-title":"Isolation and characterization of the gene encoding 2,3-oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae","volume":"91","author":"Shi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijbiomac.2015.12.072","article-title":"Current updates on computer aided protein modeling and designing","volume":"85","author":"Khan","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.jsbmb.2018.09.001_bib0200","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/cbic.200500084","article-title":"Histidine residue at position 234 of oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae simultaneously influences cyclization, rearrangement, and deprotonation reactions","volume":"6","author":"Wu","year":"2005","journal-title":"ChemBioChem"},{"issue":"6","key":"10.1016\/j.jsbmb.2018.09.001_bib0205","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1021\/ja963227w","article-title":"Methodology for the preparation of pure recombinant S. Cerevisiae lanosterol synthase using a baculovirus expression system. Evidence that oxirane cleavage and A-ring formation are concerted in the biosynthesis of lanosterol from 2,3-oxidosqualene","volume":"119","author":"Corey","year":"1997","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.jsbmb.2018.09.001_bib0210","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1039\/b616857b","article-title":"Enzymatic synthesis of cyclic triterpenes","volume":"24","author":"Abe","year":"2007","journal-title":"Nat. Prod. Rep."},{"issue":"7","key":"10.1016\/j.jsbmb.2018.09.001_bib0215","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1021\/ol053134w","article-title":"Tryptophan 232 within oxidosqualene\u2212lanosterol cyclase from Saccharomyces cerevisiae influences rearrangement and deprotonation but not cyclization reactions","volume":"8","author":"Wu","year":"2006","journal-title":"Org. Lett."},{"issue":"21","key":"10.1016\/j.jsbmb.2018.09.001_bib0220","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1021\/ol802036c","article-title":"Importance of Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase tyrosine 707 residue for chair-boat bicyclic ring formation and deprotonation reactions","volume":"10","author":"Wu","year":"2008","journal-title":"Org. Lett."},{"issue":"3","key":"10.1016\/j.jsbmb.2018.09.001_bib0225","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/jm0302997","article-title":"Evaluation of docking performance: comparative data on docking algorithms","volume":"47","author":"Kontoyianni","year":"2004","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.jsbmb.2018.09.001_bib0230","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1021\/jm060999m","article-title":"Prediction of protein-ligand interactions. Docking and scoring: successes and gaps","volume":"49","author":"Leach","year":"2006","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.09.001_bib0235","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1747-0285.2007.00571.x","article-title":"Signposts of docking and scoring in drug design","volume":"70","author":"Gani","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"issue":"21","key":"10.1016\/j.jsbmb.2018.09.001_bib0240","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1021\/ol061549r","article-title":"Phenylalanine 445 within oxidosqualene\u2212lanosterol cyclase from Saccharomyces cerevisiae influences C-ring cyclization and deprotonation reactions","volume":"8","author":"Wu","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0245","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1002\/ejoc.200900638","article-title":"Differential stereocontrolled formation of tricyclic triterpenes by mutation of tyrosine 99 of the oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae","volume":"33","author":"Wu","year":"2009","journal-title":"Eur. J. Org. Chem."},{"issue":"9","key":"10.1016\/j.jsbmb.2018.09.001_bib0250","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0223-5234(93)90026-B","article-title":"Synthesis and biological activity of 19-azasqualene 2,3-epoxide as inhibitor of 2,3-oxidosqualene cyclase","volume":"28","author":"Ceruti","year":"1993","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.09.001_bib0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-2275(20)37449-6","article-title":"Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin","volume":"38","author":"Morand","year":"1997","journal-title":"J. Lipid Res."},{"issue":"19","key":"10.1016\/j.jsbmb.2018.09.001_bib0260","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1016\/j.bmcl.2010.07.131","article-title":"Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors","volume":"20","author":"Watanabe","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2015.12.025","article-title":"Arylpiperidines as a new class of oxidosqualene cyclase inhibitors","volume":"109","author":"Keller","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.09.001_bib0270","first-page":"118","article-title":"Vitamin D: the \u201csunshine\u201d vitamin","volume":"3","author":"Nair","year":"2012","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0275","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jsbmb.2017.01.020","article-title":"Effects of vitamin D status on oral health","volume":"175","author":"Uwitonze","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.09.001_bib0280","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mycmed.2016.10.003","article-title":"Vitamin D3 a new drug against Candida albicans","volume":"27","author":"Bouzid","year":"2017","journal-title":"J. Med. Vet. Mycol."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0285","series-title":"As bases farmacol\u00f3gicas da terap\u00eautica de Goodman & Gilman","author":"Brunton","year":"2012"},{"issue":"3-4","key":"10.1016\/j.jsbmb.2018.09.001_bib0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11046-014-9735-7","article-title":"The calcium channel blocker verapamil inhibits oxidative stress response in Candida albicans","volume":"177","author":"Yu","year":"2014","journal-title":"Mycopathologia"},{"issue":"4","key":"10.1016\/j.jsbmb.2018.09.001_bib0295","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1567-1364.12150","article-title":"Inhibitory effect of verapamil on Candida albicans hyphal development, adhesion and gastrointestinal colonization","volume":"14","author":"Yu","year":"2014","journal-title":"FEMS Yeast Res."},{"issue":"suppl. 2","key":"10.1016\/j.jsbmb.2018.09.001_bib0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/00003495-198800352-00035","article-title":"Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy","volume":"35","author":"Br\u00e4utigam","year":"1988","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.jsbmb.2018.09.001_bib0305","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2165\/00003495-200262070-00005","article-title":"Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections","volume":"62","author":"Lamb","year":"2002","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jsbmb.2018.09.001_bib0310","first-page":"298","article-title":"A novel approach to prevent candidiasis associated with long term administration of cephalosporins","volume":"6","author":"Chaudhary","year":"2013","journal-title":"J. Pharm. Res."},{"issue":"3","key":"10.1016\/j.jsbmb.2018.09.001_bib0315","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/CCM.0000000000000746","article-title":"Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime","volume":"43","author":"Jensen","year":"2015","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.09.001_bib0320","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/clinids\/14.1.56","article-title":"Safety profile and efficacy of cefotaxime for the treatment of hospitalized children","volume":"14","author":"Jacobs","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jsbmb.2018.09.001_bib0325","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/bcp.12785","article-title":"Repurposing some older drugs that cross the blood\u2013brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma","volume":"81","author":"Rundle-Thiele","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsbmb.2018.09.001_bib0330","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1568009615666141229152812","article-title":"Potential anti-cancer drugs commonly used for other indications","volume":"15","author":"Hanusova","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"issue":"8","key":"10.1016\/j.jsbmb.2018.09.001_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042120","article-title":"A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo","volume":"7","author":"Petty","year":"2012","journal-title":"PLoS One"},{"issue":"3\u20134","key":"10.1016\/j.jsbmb.2018.09.001_bib0340","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ddstr.2011.10.002","article-title":"Drug repurposing from an academic perspective","volume":"8","author":"Oprea","year":"2011","journal-title":"Drug Discov. Today Ther. Strateg."},{"issue":"3","key":"10.1016\/j.jsbmb.2018.09.001_bib0345","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/gm326","article-title":"Drug repositioning for personalized medicine","volume":"4","author":"Li","year":"2012","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.09.001_bib0350","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/derm.3.4.15027","article-title":"Antimicrobial implications of vitamin D","volume":"3","author":"Youssef","year":"2011","journal-title":"Dermatoendrocrinol"},{"issue":"7","key":"10.1016\/j.jsbmb.2018.09.001_bib0355","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/0022034512446342","article-title":"Association among vitamin D, oral candidiasis, and calprotectinemia in HIV","volume":"91","author":"Sroussi","year":"2012","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0360","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/jiq008","article-title":"1,25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses","volume":"203","author":"Khoo","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.jsbmb.2018.09.001_bib0365","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/ptr.2783","article-title":"5-lipoxygenase-inhibitory constituents from Schizandra fructus and Magnolia flos","volume":"23","author":"Lim","year":"2009","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.09.001_bib0370","doi-asserted-by":"crossref","DOI":"10.1515\/jtim-2017-0038","article-title":"Serum vitamin D levels in treatment-na\u00efve chronic hepatitis B patients","volume":"5","author":"Said","year":"2017","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.jsbmb.2018.09.001_bib0375","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/ijmy.ijmy_120_17","article-title":"Vitamin D, cell death pathways, and tuberculosis","volume":"6","author":"Wahyunitisari","year":"2017","journal-title":"Int. J. Mycobacteriol."},{"issue":"10","key":"10.1016\/j.jsbmb.2018.09.001_bib0380","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01226-17","article-title":"Mechanisms of action of vitamin D as supplemental therapy for pneumocystis pneumonia","volume":"61","author":"Lei","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.jsbmb.2018.09.001_bib0385","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/infdis\/jiv033","article-title":"Bimodal influence of vitamin d in host response to systemic Candida infection\u2014vitamin d dose matters","volume":"212","author":"Lim","year":"2015","journal-title":"J. Infect. Dis."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018303352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018303352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:01:26Z","timestamp":1760745686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076018303352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":77,"alternative-id":["S0960076018303352"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2018.09.001","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2018.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}